Literature DB >> 3936299

Adjuvant activity of chitin derivatives in mice and guinea-pigs.

K Nishimura, S Nishimura, N Nishi, F Numata, Y Tone, S Tokura, I Azuma.   

Abstract

Adjuvant activity of chitin derivatives was examined in guinea-pigs and mice. Among derivatives of chitin tested, 30 and 70% deacetylated chitin (DAC-30 and DAC-70), were active as adjuvants for the circulating-antibody formation to bacterial alpha-amylase and for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine. DAC-70 enhanced the helper T cell function, the generation of alloreactive cytotoxic T lymphocytes, and the activity of natural killer cells in mice, however, it was inactive as mitogen. Other derivatives of chitin showed weaker or no adjuvant activity compared with DAC-70. Carboxymethyl-, hydroxyethyl and dihydroxypropyl-chitin showed weak mitogenic activities on normal spleen cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936299     DOI: 10.1016/0264-410x(85)90127-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery.

Authors:  Takahiro Nagamoto; Yoshiyuki Hattori; Kozo Takayama; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

2.  Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.

Authors:  David A Zaharoff; Connie J Rogers; Kenneth W Hance; Jeffrey Schlom; John W Greiner
Journal:  Vaccine       Date:  2006-12-04       Impact factor: 3.641

3.  Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis.

Authors:  Barlas Büyüktimkin; Qun Wang; Paul Kiptoo; John M Stewart; Cory Berkland; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2012-03-13       Impact factor: 4.939

4.  Subacute systemic toxicity assessment of beta-tricalcium phosphate/carboxymethyl-chitin composite implanted in rat femur.

Authors:  Kazuaki Muramatsu; Kousuke Oba; Daisuke Mukai; Kazunari Hasegawa; Shingo Masuda; Yusuke Yoshihara
Journal:  J Mater Sci Mater Med       Date:  2007-03       Impact factor: 3.896

5.  Glycated chitosan as a new non-toxic immunological stimulant.

Authors:  Sheng Song; Feifan Zhou; Robert E Nordquist; Raoul Carubelli; Hong Liu; Wei R Chen
Journal:  Immunopharmacol Immunotoxicol       Date:  2009-06       Impact factor: 2.730

6.  Modulatory effects of chitosan adipate on the T and B lymphocyte subsets in mice.

Authors:  Bozena Obmińska-Mrukowicz; Marianna Szczypka; Bartosz Gaweda
Journal:  J Vet Sci       Date:  2006-06       Impact factor: 1.672

Review 7.  Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery.

Authors:  Tarek A Ahmed; Bader M Aljaeid
Journal:  Drug Des Devel Ther       Date:  2016-01-28       Impact factor: 4.162

Review 8.  Needle-Free Immunization with Chitosan-Based Systems.

Authors:  Bijay Singh; Sushila Maharjan; Princy Sindurakar; Ki-Hyun Cho; Yun-Jaie Choi; Chong-Su Cho
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

Review 9.  Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine.

Authors:  Xiaosong Li; Min Min; Nan Du; Ying Gu; Tomas Hode; Mark Naylor; Dianjun Chen; Robert E Nordquist; Wei R Chen
Journal:  Clin Dev Immunol       Date:  2013-03-04

Review 10.  How the Lack of Chitosan Characterization Precludes Implementation of the Safe-by-Design Concept.

Authors:  Cíntia Marques; Claudia Som; Mélanie Schmutz; Olga Borges; Gerrit Borchard
Journal:  Front Bioeng Biotechnol       Date:  2020-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.